共 50 条
- [23] Immunogenicity and Safety of High Dose vs. Standard Dose of inactivated Influenza Vaccine in Patients with rheumatoid Arthritis ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (08): : 756 - 757
- [24] Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1459 - 1466
- [27] Estimating Standard-Dose and High-Dose Fluzone Vaccine Efficacies for Influenza A Based on Hemagglutination Inhibition Titers JOURNAL OF INFECTIOUS DISEASES, 2024,
- [28] Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial LANCET RHEUMATOLOGY, 2020, 2 (01): : E14 - E23